Medtronic wins $101.2M in damages from NuVasive

Medtronic has successfully sued NuVasive for patent infringement to the tune of $101.2 million. A jury awarded the judgment over claims related to medical devices used in spinal surgery, according to numerous reports.

Meanwhile the federal jury, convened in San Diego, held Medtronic liable for $660,000 in damages to NuVasive for infringing one of its patents.

Bloomberg News reported that the verdict in Medtronic's favor is the 14th-largest jury award in the U.S. in 2011 and the fourth-largest for a patent-infringement claim.

NuVasive said in a statement that it will “aggressively challenge this verdict.”

Fridley, Minn.-based Medtronic has around 41,000 employees and reported revenues of $14.6 billion in 2009. NuVasive is headquartered in San Diego, employs around 350 and took in $154 million in 2007. Both companies are publicly traded.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup